These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32316911)

  • 1. Controlled trial of lovastatin combined with an open-label treatment of a parent-implemented language intervention in youth with fragile X syndrome.
    Thurman AJ; Potter LA; Kim K; Tassone F; Banasik A; Potter SN; Bullard L; Nguyen V; McDuffie A; Hagerman R; Abbeduto L
    J Neurodev Disord; 2020 Apr; 12(1):12. PubMed ID: 32316911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distance delivery of a spoken language intervention for school-aged and adolescent boys with fragile X syndrome.
    McDuffie A; Banasik A; Bullard L; Nelson S; Feigles RT; Hagerman R; Abbeduto L
    Dev Neurorehabil; 2018 Jan; 21(1):48-63. PubMed ID: 28956679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Language Intervention Using Distance Video-Teleconferencing: A Pilot Study of Young Boys With Fragile X Syndrome and Their Mothers.
    McDuffie A; Oakes A; Machalicek W; Ma M; Bullard L; Nelson S; Abbeduto L
    Am J Speech Lang Pathol; 2016 Feb; 25(1):46-66. PubMed ID: 26502382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inferential language use by school-aged boys with fragile X syndrome: Effects of a parent-implemented spoken language intervention.
    Nelson S; McDuffie A; Banasik A; Tempero Feigles R; Thurman AJ; Abbeduto L
    J Commun Disord; 2018; 72():64-76. PubMed ID: 29494850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parent-mediated interventions for promoting communication and language development in young children with Down syndrome.
    O'Toole C; Lee AS; Gibbon FE; van Bysterveldt AK; Hart NJ
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012089. PubMed ID: 30321454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Spoken-Language Intervention for School-Aged Boys With Fragile X Syndrome.
    McDuffie A; Machalicek W; Bullard L; Nelson S; Mello M; Tempero-Feigles R; Castignetti N; Abbeduto L
    Am J Intellect Dev Disabil; 2016 May; 121(3):236-65. PubMed ID: 27119214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Providing a parent-implemented language intervention to a young male with fragile X syndrome: brief report.
    Oakes A; Ma M; McDuffie A; Machalicek W; Abbeduto L
    Dev Neurorehabil; 2015 Feb; 18(1):65-8. PubMed ID: 25325341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distance delivery of a parent-implemented language intervention for young boys with fragile X syndrome.
    Bullard L; McDuffie A; Abbeduto L
    Autism Dev Lang Impair; 2017; 2():. PubMed ID: 30417116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Communication interventions for autism spectrum disorder in minimally verbal children.
    Brignell A; Chenausky KV; Song H; Zhu J; Suo C; Morgan AT
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012324. PubMed ID: 30395694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of lovastatin on behavior in children and adults with fragile X syndrome: an open-label study.
    Çaku A; Pellerin D; Bouvier P; Riou E; Corbin F
    Am J Med Genet A; 2014 Nov; 164A(11):2834-42. PubMed ID: 25258112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Family and Caregiver Characteristics Contribute to Caregiver Change in Use of Strategies and Growth in Child Spoken Language in a Parent-Implemented Language Intervention in Fragile X Syndrome.
    Potter SN; Bullard L; Banasik A; Feigles RT; Nguyen V; McDuffie A; Thurman AJ; Hagerman R; Abbeduto L
    Perspect ASHA Spec Interest Groups; 2022 Dec; 7(6):1630-1644. PubMed ID: 36778100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responsive Parenting as a Target for Telehealth Language Interventions in Fragile X Syndrome: Implications for Scalability and Best Practices.
    Bullard L; Abbeduto L
    Semin Speech Lang; 2021 Aug; 42(4):287-300. PubMed ID: 34311481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expressive language sampling as a source of outcome measures for treatment studies in fragile X syndrome: feasibility, practice effects, test-retest reliability, and construct validity.
    Abbeduto L; Berry-Kravis E; Sterling A; Sherman S; Edgin JO; McDuffie A; Hoffmann A; Hamilton D; Nelson M; Aschkenasy J; Thurman AJ
    J Neurodev Disord; 2020 Mar; 12(1):10. PubMed ID: 32204695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized study of parent- versus child-directed intervention for Dutch toddlers with DLD.
    Zwitserlood-Nijenhuis MA; Wiefferink CH; Gerrits E
    Int J Lang Commun Disord; 2023; 58(5):1768-1782. PubMed ID: 37248804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomised controlled trial of the effectiveness of parent-based models of language intervention for 2- to 3-year-old children with speech, language and communication needs (SLCN) in areas of social disadvantage.
    Gibbard D; Roulstone S; Kandala Shadrack NI; Morgan L; Harding S; Smith C; Markham C
    Int J Lang Commun Disord; 2024; 59(4):1517-1537. PubMed ID: 38285603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining Lovastatin and Minocycline for the Treatment of Fragile X Syndrome: Results From the LovaMiX Clinical Trial.
    Champigny C; Morin-Parent F; Bellehumeur-Lefebvre L; Çaku A; Lepage JF; Corbin F
    Front Psychiatry; 2021; 12():762967. PubMed ID: 35058813
    [No Abstract]   [Full Text] [Related]  

  • 19. A randomised controlled trial and economic evaluation of direct versus indirect and individual versus group modes of speech and language therapy for children with primary language impairment.
    Boyle J; McCartney E; Forbes J; O'Hare A
    Health Technol Assess; 2007 Jul; 11(25):iii-iv, xi-xii, 1-139. PubMed ID: 17610807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parental Responsivity and Child Communication During Mother-Child and Father-Child Interactions in Fragile X Syndrome.
    Potter SN; Harvey D; Sterling A; Abbeduto L
    J Speech Lang Hear Res; 2024 Mar; 67(3):939-959. PubMed ID: 38407074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.